AD2P (also locally referred to as the “Plateforme de Criblage Marseille-Luminy” (PCML)) plays a significant role in the research field of antivirals against emerging viruses.

Indeed, the facility has developed and offers expertise in the screening of viral enzyme inhibitors, protein/protein interactions, clinical virus isolates, the supply of chemical libraries, as well as in the development of new technologies and drug design.

Description

AD2P (also locally referred to as the “Plateforme de Criblage Marseille-Luminy” (PCML)) plays a significant role in the research field of antivirals against emerging viruses.

Indeed, the facility has developed and offers expertise in the screening of viral enzyme inhibitors, protein/protein interactions, clinical virus isolates, the supply of chemical libraries, as well as in the development of new technologies and drug design.

Partner institution

Aix-Marseille Université

Scientific domain

LS1_11 - Chemical biology - Molecules of Life: Biological Mechanisms, Structures and Functions LS7_9 - Public health and epidemiology - Prevention, Diagnosis and Treatment of Human Diseases LS6_6 - Infectious diseases - Immunity, Infection and Immunotherapy LS8_4 - Population biology, population dynamics, population genetics - Environmental Biology, Ecology and Evolution LS9_2 - Applied genetics, gene editing and transgenic organisms - Biotechnology and Biosystems Engineering

Keywords

HTS Antivirals Emerging Viruses 2P2I